tiprankstipranks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market
RCUS
Arcus Biosciences
RESEARCH TOOLSreports
Want to see RCUS full AI Analyst Report?

Arcus Biosciences (RCUS) Income Statement

544 Followers

Arcus Biosciences Income Statement

Last quarter (Q4 2025), Arcus Biosciences's total revenue was $33.00M, an increase of 26.92% from the same quarter last year. In Q4, Arcus Biosciences's net income was $-98.00M. See Arcus Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 247.00M$ 258.00M$ 117.00M$ 112.00M$ 383.00M
Gross Profit
$ 237.00M$ 258.00M$ 117.00M$ 112.00M$ 383.00M
Operating Expenses
$ 623.00M$ 588.00M$ 457.00M$ 392.00M$ 329.00M
Depreciation and Amortization
$ 10.00M$ 10.00M$ 8.00M$ 6.00M$ 4.00M
EBITDA
$ -335.00M$ -269.00M$ -291.00M$ -258.00M$ 59.00M
Operating Income
$ -386.00M$ -330.00M$ -340.00M$ -280.00M$ 54.00M
Other Income/Expenses
$ 33.00M$ 47.00M$ 39.00M$ 14.00M$ 1.00M
Pretax Income
$ -353.00M$ -283.00M$ -301.00M$ -266.00M$ 55.00M
Net Income
$ -353.00M$ -283.00M$ -307.00M$ -267.00M$ 53.00M
Per Share Metrics
Basic EPS
$ -3.29$ -3.14$ -4.15$ -3.71$ 0.76
Diluted EPS
$ -3.29$ -3.14$ -4.15$ -3.71$ 0.71
Weighted Average Shares Outstanding
 107.40M 90.10M 74.00M 72.00M 69.35M
Weighted Average Shares Outstanding (Diluted)
 107.40M 90.10M 74.00M 72.00M 73.97M
Currency in USD

Arcus Biosciences Earnings and Revenue History